E-learning to Prevent Drug Errors in Anesthesia (ELPdrug)

April 17, 2019 updated by: University Hospital, Montpellier

Evaluation of an E-learning to Prevent Drug Errors in Anesthesia.

The purpose of this observational study is to assess the efficiency of an e-learning in order to put into practice some preventive measures to avoid medication errors during anesthesia.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Before the study, the investigators selected 15 preventive measures to avoid medication errors during anesthesia. These measures were learned to the entire anesthesia team (nurse, resident and anesthesiologist) during conventional meetings. An initial evaluation of the application of these measures will be carried out before the introduction of e-learning. This assessment will be conducted by nurses without the knowledge of the anesthetic team evaluated. After this initial evaluation, e-learning will be broadcast on the hospital intranet. Then a second evaluation of the application of the preventive measures will be carried out 6 month and 1 year after the introduction of e-learning.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Montpellier, France, 34295
        • UHMontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing anesthesia in Lapeyronie Hospital

Description

Inclusion criteria:

  • patient undergoing regional and/or general anesthesia

Exclusion criteria:

  • only sedation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of application of the preventive measures after versus before the use of an e-learning.
Time Frame: 1 day
Percentage of application of the preventive measures after versus before the use of an e-learning.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the application of each of the 15 preventive measureaccording to various clinical parameters
Time Frame: 1 day
Evaluation of the application of each of the 15 preventive measures according to the clinical parameters of the patients followed (age of the patient, physical state of the ASA, type of surgery, type of anesthesia, period of the day or of the week, surgery of Emergency or elective.)emergency or elective surgery. In each completed questionnaire, these clinical parameters are noted.)
1 day

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the application of the preventive measures following the introduction of the e-learning in the anesthesia team.
Time Frame: 6 month and 1 year
The evaluation of the application of the preventive measures will be assess following the introduction of the e-learning in the anesthesia team.
6 month and 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Montpellier

Investigators

  • Study Director: BIBOULET Philippe, MD, PhD, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2017

Primary Completion (Actual)

November 30, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

July 5, 2017

First Submitted That Met QC Criteria

July 25, 2017

First Posted (Actual)

July 28, 2017

Study Record Updates

Last Update Posted (Actual)

April 18, 2019

Last Update Submitted That Met QC Criteria

April 17, 2019

Last Verified

September 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • RECHMPL17_0226

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical Errors : Drugs Errors During Anesthesia

Clinical Trials on Elearning

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe